Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session
$ACER
$ACLX
$AMAM
$ARMP
Biotechnology: Pharmaceutical Preparations
Health Care
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Gainers
- Ambrx Biopharma Inc. (NYSE:AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate.
- ClearOne, Inc. (NASDAQ:CLRO) gained 85% to $1.51 after the company and Shure Incorporated announced they reached a global settlement of all pending legal disputes.
- Rockley Photonics Holdings Limited (NYSE:RKLY) rose 48.3% to $0.4218 after jumping 18% on Thursday. Rockley Photonics, last month, reported worse-than-expected Q3 sales results and issued 2022 revenue guidance below estimates.
- Marin Software Incorporated (NASDAQ:MRIN) shares climbed 34.5% to $1.52. Marin Software joined the Walmart Platform Partner program as an API partner.
- UpHealth, Inc. (NYSE:UPH) shares climbed 30.6% to $3.06. Healthcare transformation expert Timothy Wilde joined UpHealth as Chief Technology Officer.
- China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) gained 29.4% to $2.7953.
- Hello Group Inc. (NASDAQ:MOMO) jumped 29% to $8.77. Morgan Stanley upgraded Hello Group from Equal-Weight to Overweight and raised the price target from $5 to $9.
- Arcellx, Inc. (NASDAQ:ACLX) gained 27.8% to $27.71. Kite, a Gilead Sciences Inc company, announced a global strategic collaboration to co-develop and co-commercialize Arcellx’s lead late-stage product candidate, CART-ddBCMA, for relapsed or refractory multiple myeloma. Arcellx also announced interim CART-ddBCMA Phase 1 results (October 31, 2022 cutoff date), demonstrating deep and durable responses.
- Baudax Bio, Inc. (NASDAQ:BXRX) shares gained 23% to $5.01 after the company announced initiation of a Phase II clinical trial evaluationg BX1000 in patients undergoing surgery.
- Daktronics, Inc. (NASDAQ:DAKT) jumped 23% to $2.1518. Daktronics delayed its earnings release to address the determination that there is 'substantial doubt' over its ability to continue as a going concern.
- Acer Therapeutics Inc. (NASDAQ:ACER) gained 21% to $1.90. Acer Therapeutics recently reported a $1.5 million private placement.
- HUYA Inc. (NYSE:HUYA) rose 20.6% to $3.39.
- NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) shares rose 20.4% to $2.0907 after gaining 25% on Thursday. Ladenburg Thalmann recently initiated coverage on NeuroBo Pharmaceuticals with a Buy rating and announced a price target of $6.
- Ensysce Biosciences, Inc. (NASDAQ:ENSC) gained 19.2% to $1.1799.
- SpringBig Holdings, Inc. (NASDAQ:SBIG) jumped 18.4% to $0.7578.
- Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS) rose 18.3% to $0.1341. Powerbridge Technologies, last month, announced the strategic acquisition of DTI Group.
- Domo, Inc. (NASDAQ:DOMO) gained 17.7% to $17.53 following better-than-expected Q3 results.
- Armata Pharmaceuticals, Inc. (NYSE:ARMP) jumped 17.7% to $2.26.
- Phreesia, Inc. (NYSE:PHR) rose 16.4% to $31.08 after the company posted upbeat Q3 sales and raised FY23 revenue guidance.
- Braemar Hotels & Resorts Inc. (NYSE:BHR) gained 16.2% to $4.01. Braemar Hotels & Resorts announced an increase in quarterly dividend from $0.01 per share to $0.05 per share and authorized $25 million for share repurchases.
- DocuSign, Inc. (NASDAQ:DOCU) rose 15.8% to $50.68 after the company reported better-than-expected financial results for its third quarter and issued strong guidance. Piper Sandler upgraded the stock from Underweight to Neutral and lowered the price target from $54 to $50.
- iClick Interactive Asia Group Limited (NASDAQ:ICLK) gained 14.9% to $4.0901.
- Johnson Outdoors Inc. (NASDAQ:JOUT) jumped 12.8% to $64.83 following better-than-expected quarterly results.
- Ikena Oncology, Inc. (NASDAQ:IKNA) gained 12.7% to $3.09.
- Harpoon Therapeutics, Inc. (NASDAQ:HARP) jumped 11.8% to $1.07.
- Ecoark Holdings, Inc. (NASDAQ:ZEST) gained 9.3% to $0.59.
- WaveDancer, Inc. (NASDAQ:WAVD) jumped 9.3% to $0.66.
- Korea Electric Power Corporation (NYSE:KEP) rose 8.9% to $8.07.
- National Beverage Corp. (NASDAQ:FIZZ) gained 8% to $52.33 following Q2 results.
- China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) rose 8% to $0.5199 after dropping 13% on Thursday.
- Broadcom Inc. (NASDAQ:AVGO) gained 3.7% to $550.93 as the company reported better-than-expected results for its fourth quarter and issued strong sales forecast for the current quarter. Broadcom also raised the quarterly dividend by 12% to $4.60 per share.
Losers
- Getaround Inc. (NYSE:GETR) shares tumbled 64.8% to $3.10. Getaround reported closing of business combination with InterPrivate II Acquisition Corp.
- Grom Social Enterprises, Inc. (NASDAQ:GROM) dipped 58% to $1.6195. Grom Social Enterprises priced $5 million public offering of 1,415,682 units at a price of $2.89 per unit
- Autolus Therapeutics plc (NASDAQ:AUTL) fell 34.9% to $1.9475 after the company announced pricing of a public offering. The company’s Phase 2 pivotal FELIX trial of obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) adult Acute Lymphoblastic Leukemia (ALL) has met its primary endpoint of Overall Remission Rate (ORR).
- Meta Materials Inc. (NASDAQ:MMAT) dropped 24.6% to $1.3799. Meta Materials recently announced FINRA has processed and announced the corporate action of exchanging META's Series A Preferred shares for shares of common stock of Next Bridge Hydrocarbons on its daily list.
- My Size, Inc. (NASDAQ:MYSZ) fell 24% to $3.61.
- Winc, Inc. (NYSE:WBEV) dropped 19% to $0.17.
- Erasca, Inc. (NASDAQ:ERAS) fell 17.6% to $6.03 after the company priced a 15,384,616 share offering at $6.50 per share.
- BioVie Inc. (NASDAQ:BIVI) dropped 16.9% to $7.56.
- Flora Growth Corp. (NASDAQ:FLGC) fell 16.8% to $0.37 after the company announced pricing of a $5 million registered direct offering.
- Sunlands Technology Group (NYSE:STG) declined 16.4% to $6.18.
- Rent the Runway, Inc. (NASDAQ:RENT) fell 15% to $2.0150. Rent The Runway shares jumped 74% on Thursday after the company reported better-than-expected Q3 sales results.
- Bluejay Diagnostics, Inc. (NASDAQ:BJDX) declined 15% to $0.45.
- Save Foods, Inc. (NASDAQ:SVFD) dipped 14.3% to $0.8999.
- Pharvaris N.V. (NASDAQ:PHVS) shares fell 14.2% to $9.83. Pharvaris shares jumped 339% on Thursday after the company reported top-line Phase 2 data from the RAPIDe-1 study of PHVS416 for the on-demand treatment of HAE attacks.
- SHF Holdings, Inc. (NASDAQ:SHFS) dropped 13.6% to $3.4995.
- Sono Group N.V. (NASDAQ:SEV) fell 13.2% to $0.9632. Sono Group shares dropped 5% on Thursday after the company reported worse-than-expected Q3 EPS results.
- Torrid Holdings Inc. (NYSE:CURV) declined 13.1% to $3.7099 after the company reported worse-than-expected Q3 EPS and sales results and issued Q4 2022 and FY22 revenue guidance below estimates.
- Tivic Health Systems, Inc. (NASDAQ:TIVC) dropped 12.3% to $0.9550. Tivic Health and Reliefband Technologies, LLC terminated acquisition agreement.
- Lululemon Athletica Inc. (NASDAQ:LULU) fell 12.3% to $328.35. Lululemon posted upbeat results for its third quarter, but issued weak holiday-quarter guidance.
- Party City Holdco Inc. (NYSE:PRTY) fell 12.1% to $0.5210.
- TransCode Therapeutics, Inc. (NASDAQ:RNAZ) shares fell 11.3% to $0.6441after declining over 25% on Thursday. TransCode Therapeutics recently announced withdrawal of the Registration Statement on Form S-1 filed on November 28, 2022 for a share offering for up to 12.5 million.
Also check this out Bitcoin Tops This Key Level; The Graph Emerges As Top Gainer